Erste Asset Management GmbH Has $546,000 Stock Holdings in CorVel Co. (NASDAQ:CRVL)

Erste Asset Management GmbH lifted its stake in shares of CorVel Co. (NASDAQ:CRVL) by 182.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,800 shares of the business services provider’s stock after purchasing an additional 3,100 shares during the period. Erste Asset Management GmbH’s holdings in CorVel were worth $546,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Boston Trust Walden Corp raised its position in shares of CorVel by 196.8% during the fourth quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider’s stock worth $76,775,000 after purchasing an additional 457,538 shares during the period. State Street Corp raised its position in CorVel by 0.8% during the third quarter. State Street Corp now owns 360,068 shares of the business services provider’s stock valued at $117,703,000 after buying an additional 2,959 shares during the period. Charles Schwab Investment Management Inc. raised its position in CorVel by 203.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 261,644 shares of the business services provider’s stock valued at $29,111,000 after buying an additional 175,408 shares during the period. Geode Capital Management LLC raised its position in CorVel by 3.9% during the third quarter. Geode Capital Management LLC now owns 253,870 shares of the business services provider’s stock valued at $83,000,000 after buying an additional 9,571 shares during the period. Finally, Raymond James Financial Inc. acquired a new position in CorVel during the fourth quarter valued at $25,123,000. 51.36% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered CorVel from a “buy” rating to a “hold” rating in a research report on Thursday.

Insiders Place Their Bets

In other CorVel news, Director Alan Hoops sold 10,200 shares of the company’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total value of $1,187,178.00. Following the transaction, the director now directly owns 118,213 shares of the company’s stock, valued at $13,758,811.07. This represents a 7.94 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Brandon O’brien sold 1,523 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total value of $182,089.88. Following the sale, the chief financial officer now owns 17,142 shares of the company’s stock, valued at approximately $2,049,497.52. This trade represents a 8.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,200 shares of company stock valued at $3,824,115 in the last three months. Insiders own 47.57% of the company’s stock.

CorVel Trading Up 3.1 %

NASDAQ:CRVL opened at $106.65 on Friday. The firm has a market capitalization of $5.48 billion, a price-to-earnings ratio of 62.74 and a beta of 1.06. CorVel Co. has a 1-year low of $76.20 and a 1-year high of $128.61. The business’s fifty day moving average price is $112.21 and its 200 day moving average price is $114.15.

CorVel (NASDAQ:CRVL) last issued its earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.